Merck & Siemens join forces to accelerate AI drug discovery and development
Merck and Siemens signed new MoU extending their strategic partnership to accelerate digital transformation in the life science industry
Merck and Siemens signed new MoU extending their strategic partnership to accelerate digital transformation in the life science industry
Collaboration combines Lunit's AI expertise with Agilent's diagnostic leadership to revolutionize biomarker testing and enhance precision medicine capabilities
Clinical evidence has consistently highlighted lacosamide’s efficacy and safety.
The goal is to deliver greater value to customers, doctors, and the broader healthcare ecosystem
This predictive technology empowers people with diabetes to take preventive action before complications arise
Conducted entirely in Europe across forty sites in five countries, this rigorous study met all clinical endpoints
The lab will facilitate the development of herbal and natural-based solutions
Pete Pharma will leverage FABRX’s extensive foundation of scientific validation to deliver a commercially viable, pharmacy-ready solution in the US
The state-of-the-art facility is a 450-bedded, multi-specialty tertiary care hospital,
Subscribe To Our Newsletter & Stay Updated